This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
By This Author:
Page 2 of 368

'Mad Money' Lightning Round: Two Thumbs Up for Northrop Grumman

By Scott Rutt

Cramer likes Lowe's and Service Corp. but he's avoiding Mobileye.

06:00AM 03/24/15

Jim Cramer's 'Mad Money' Recap: 5 'What If' Scenarios That Could Change Markets

By Scott Rutt

Every good investor needs to challenge his or her thinking, Cramer says.

08:25PM 03/23/15

'Mad Money' Lightning Round: Buy, Buy, Buy Whole Foods Markets

By Scott Rutt

Cramer likes Celladon and Sirius XM Radio, thinks Centene is amazing and is avoiding King Digital and Virgin America.

06:00AM 03/21/15

Jim Cramer's Top Takeaways: Papa Murphy's, Nike, Prothena

By Scott Rutt

Cramer is excited by Papa Murphy's business model while Prothena could have a hit with its Parkinson's drug.

06:00AM 03/21/15

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

By Scott Rutt

Cramer says it's time to take some profits and raise cash for the next speed bump. He'll be watching company earnings from Sonic, Paychex and GameStop, among others.

08:24PM 03/20/15

'Mad Money' Lightning Round: I Really Like Sonic so Buy, Buy, Buy

By Scott Rutt

BioCryst Pharmaceuticals doesn't have what Cramer wants and he prefers Skyworks Solutions over InvenSense.

06:00AM 03/20/15

Jim Cramer's Top Takeaways: Esperion Therapeutics, Platform Specialty Products

By Scott Rutt

Cramer is excited about Esperion's anti-cholesterol drug and Platform Specialty's high level of service.

06:00AM 03/20/15

Jim Cramer's 'Mad Money' Recap: The Markets Are Getting It All Wrong

By Scott Rutt

Jim Cramer says there are a lot more winners than losers when commodity prices fall.

08:23PM 03/19/15

'Mad Money' Lightning Round: I'm Staying Away From Five Below

By Scott Rutt

Cramer isn't crazy about Dicerna Pharmaceuticals and Ziopharm Oncology but he likes Akamai and Lion Biotechnologies.

06:00AM 03/19/15

Jim Cramer's Top Takeaways: Starbucks, Magellan Mainstream, Regeneron

By Scott Rutt

Cramer says Starbucks is a great stock with a great CEO and likes Magellan Mainstream's long-term thinking.

06:00AM 03/19/15

Page 2 of 368

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs